We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
UK diagnostic company Oxford Immunotec has collaborated with the UK COVID-19 human challenge study to analyse the T cell responses to SARS-CoV-2 infection in participants using its T-SPOT Discovery testing kit.
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 test kit is set to be used for T cell testing in the UK Com-Cov trial, which is evaluating different combinations of approved COVID-19 vaccines.